Table 3.
Patient and tumor characteristics of 38,634 men with localized prostate cancer without primary malignancy stratified by type of local treatment.
| No local therapy (n=8,832; 22.9%) |
Prostatectomy (n=15,421; 39.9%) |
Radiation Therapy (n = 13,855; 35.9%) |
Local Destruction (n = 526; 1.4%) |
p-value# | |||||
|---|---|---|---|---|---|---|---|---|---|
| Age | < 0.001 | ||||||||
| Median | 65 | 61 | 68 | 70 | |||||
| Range | 33–103 | 33–90 | 37–99 | 43–93 | |||||
|
| |||||||||
| Race | < 0.001 | ||||||||
| White | 5673 | 64.2% | 11149 | 72.3% | 9135 | 65.9% | 372 | 70.7% | |
| Black | 1304 | 14.8% | 1969 | 12.8% | 2483 | 17.9% | 88 | 16.7% | |
| Hispanic | 689 | 7.8% | 1334 | 8.7% | 1153 | 8.3% | 35 | 6.7% | |
| Asian/Pacific Islander | 379 | 4.3% | 722 | 4.7% | 636 | 4.6% | 23 | 4.4% | |
| Native American | 45 | 0.5% | 48 | 0.3% | 40 | 0.3% | 1 | 0.2% | |
| Other/Unknown | 742 | 8.4% | 199 | 1.3% | 408 | 2.9% | 7 | 1.3% | |
|
| |||||||||
| Marital status | < 0.001 | ||||||||
| Married | 4593 | 52.0% | 11735 | 76.1% | 9242 | 66.7% | 371 | 70.5% | |
| Not married | 2050 | 23.2% | 2787 | 18.1% | 3242 | 23.4% | 114 | 21.7% | |
| Unknown | 2189 | 24.8% | 899 | 5.8% | 1371 | 9.9% | 41 | 7.8% | |
|
| |||||||||
| County poverty rate | < 0.001 | ||||||||
| Highest rate quartile | 2209 | 25.0% | 4027 | 26.1% | 3269 | 23.6% | 119 | 22.6% | |
| 3rd quartile | 2218 | 25.1% | 3740 | 24.3% | 3609 | 26.0% | 152 | 28.9% | |
| 2nd quartile | 2331 | 26.4% | 4022 | 26.1% | 3149 | 22.7% | 140 | 26.6% | |
| Lowest rate quartile | 2071 | 23.4% | 3630 | 23.5% | 3825 | 27.6% | 115 | 21.9% | |
| Unknown | 3 | 0.0% | 2 | 0.0% | 3 | 0.0% | 0 | 0.0% | |
|
| |||||||||
| SEER Registry | < 0.001 | ||||||||
| SF/Oakland | 681 | 7.7% | 654 | 4.2% | 804 | 5.8% | 15 | 2.9% | |
| Connecticut | 392 | 4.4% | 800 | 5.2% | 603 | 4.4% | 5 | 1.0% | |
| Detroit | 508 | 5.8% | 970 | 6.3% | 972 | 7.0% | 97 | 18.4% | |
| Hawaii/Alaska | 82 | 0.9% | 222 | 1.4% | 189 | 1.4% | 11 | 2.1% | |
| Iowa | 267 | 3.0% | 665 | 4.3% | 505 | 3.6% | 13 | 2.5% | |
| New Mexico | 308 | 3.5% | 347 | 2.3% | 277 | 2.0% | 3 | 0.6% | |
| Seattle | 631 | 7.1% | 1000 | 6.5% | 607 | 4.4% | 50 | 9.5% | |
| Utah | 359 | 4.1% | 477 | 3.1% | 363 | 2.6% | 36 | 6.8% | |
| Atlanta | 312 | 3.5% | 416 | 2.7% | 718 | 5.2% | 28 | 5.3% | |
| San Jose-Monterey | 328 | 3.7% | 418 | 2.7% | 570 | 4.1% | 4 | 0.8% | |
| Los Angeles | 611 | 6.9% | 1715 | 11.1% | 774 | 5.6% | 8 | 1.5% | |
| CA excluding SF/SJM/LA | 1862 | 21.1% | 3435 | 22.3% | 2550 | 18.4% | 121 | 23.0% | |
| Kentucky | 298 | 3.4% | 877 | 5.7% | 650 | 4.7% | 21 | 4.0% | |
| Louisiana | 672 | 7.6% | 950 | 6.2% | 902 | 6.5% | 33 | 6.3% | |
| New Jersey | 875 | 9.9% | 1540 | 10.0% | 1938 | 14.0% | 36 | 6.8% | |
| Greater/Rural Georgia | 646 | 7.3% | 935 | 6.1% | 1433 | 10.3% | 45 | 8.6% | |
|
| |||||||||
| NCCN Risk | < 0.001 | ||||||||
| Low | 4379 | 49.6% | 5964 | 38.7% | 4437 | 32.0% | 159 | 30.2% | |
| Intermediate | 2407 | 27.3% | 6396 | 41.5% | 5887 | 42.5% | 247 | 47.0% | |
| High | 2046 | 23.2% | 2521 | 16.3% | 3531 | 25.5% | 120 | 22.8% | |
#
Comparison across risk groups. Chi-square statistic for categorical variables and t-test for continuous variables
SEER = Surveillance, Epidemiology, and End Results; NCCN = National Comprehensive Cancer Network; SF = San Francisco; CA = California; SJM = San Jose-Monterey; LA = Los Angeles